SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-21-008132
Filing Date
2021-08-04
Accepted
2021-08-04 06:04:14
Documents
18
Period of Report
2021-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 g832118k.htm 8-K 23177
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 22770
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 26182
4 GRAPHIC hgen_logo.jpg GRAPHIC 6614
5 GRAPHIC slide_001.jpg GRAPHIC 119664
6 GRAPHIC slide_002.jpg GRAPHIC 224789
7 GRAPHIC slide_003.jpg GRAPHIC 152252
8 GRAPHIC slide_004.jpg GRAPHIC 46302
9 GRAPHIC slide_005.jpg GRAPHIC 39900
10 GRAPHIC slide_006.jpg GRAPHIC 152464
11 GRAPHIC slide_007.jpg GRAPHIC 97535
12 GRAPHIC slide_008.jpg GRAPHIC 127471
13 GRAPHIC slide_009.jpg GRAPHIC 134510
14 GRAPHIC slide_01.jpg GRAPHIC 121666
15 GRAPHIC slide_010.jpg GRAPHIC 139858
16 GRAPHIC slide_011.jpg GRAPHIC 29330
17 GRAPHIC slide_012.jpg GRAPHIC 57392
18 GRAPHIC slide_013.jpg GRAPHIC 120153
  Complete submission text file 0001214659-21-008132.txt   2237465
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 211142187
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences